Stock Price
23.40
Daily Change
0.53 2.32%
Monthly
16.94%
Yearly
-44.65%
Q3 Forecast
22.68

Celldex Therapeutics reported $-62984000 in EBITDA for its fiscal quarter ending in June of 2025.




Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Amgen USD 3.6B 147M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Celldex Therapeutics USD -62984000 1.11M Jun/2025
Glaxosmithkline GBP 3.23B 1.54B Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024